These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 19745238)

  • 1. The expert explorer: a tool for hospital data visualization and adverse drug event rules validation.
    Băceanu A; Atasiei I; Chazard E; Leroy N;
    Stud Health Technol Inform; 2009; 148():85-94. PubMed ID: 19745238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of adverse drug events: proposal of a data model.
    Chazard E; Merlin B; Ficheur G; Sarfati JC; ; Beuscart R
    Stud Health Technol Inform; 2009; 148():63-74. PubMed ID: 19745236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Data mining to generate adverse drug events detection rules.
    Chazard E; Ficheur G; Bernonville S; Luyckx M; Beuscart R
    IEEE Trans Inf Technol Biomed; 2011 Nov; 15(6):823-30. PubMed ID: 21859604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ADE scorecards: a tool for adverse drug event detection in electronic health records.
    Chazard E; Băceanu A; Ferret L; Ficheur G
    Stud Health Technol Inform; 2011; 166():169-79. PubMed ID: 21685622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of adverse drug events detection: data aggregation and data mining.
    Chazard E; Ficheur G; Merlin B; Genin M; Preda C; ; Beuscart R
    Stud Health Technol Inform; 2009; 148():75-84. PubMed ID: 19745237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Data-mining-based detection of adverse drug events.
    Chazard E; Preda C; Merlin B; Ficheur G; ; Beuscart R
    Stud Health Technol Inform; 2009; 150():552-6. PubMed ID: 19745372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse drug events prevention rules: multi-site evaluation of rules from various sources.
    Chazard E; Ficheur G; Merlin B; Serrot E; ; Beuscart R
    Stud Health Technol Inform; 2009; 148():102-11. PubMed ID: 19745240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PSIP: an overview of the results and clinical implications.
    Beuscart R
    Stud Health Technol Inform; 2011; 166():3-12. PubMed ID: 21685604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design of Adverse Drug Events-Scorecards.
    Marcilly R; Chazard E; Beuscart-Zéphir MC; Hackl W; Băceanu A; Kushniruk A; Borycki EM
    Stud Health Technol Inform; 2011; 164():377-81. PubMed ID: 21335740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toward automatic detection and prevention of adverse drug events.
    Leroy N; Chazard E; Beuscart R; Beuscart-Zephir MC;
    Stud Health Technol Inform; 2009; 143():30-5. PubMed ID: 19380911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human factors methods to support the experts' review of automatically detected adverse drug events.
    Leroy N; Bjørn B; Baceanu A; Beuscart-Zephir MC
    Stud Health Technol Inform; 2009; 150():542-6. PubMed ID: 19745370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A statistics-based approach of contextualization for adverse drug events detection and prevention.
    Chazard E; Bernonville S; Ficheur G; Beuscart R
    Stud Health Technol Inform; 2012; 180():766-70. PubMed ID: 22874295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of the Apriori algorithm for adverse drug reaction detection.
    Kuo MH; Kushniruk AW; Borycki EM; Greig D
    Stud Health Technol Inform; 2009; 148():95-101. PubMed ID: 19745239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a computerised alert system, ADEAS, to identify patients at risk for an adverse drug event.
    Rommers MK; Zegers MH; De Clercq PA; Bouvy ML; de Meijer PH; Teepe-Twiss IM; Guchelaar HJ
    Qual Saf Health Care; 2010 Dec; 19(6):e35. PubMed ID: 21127096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medication safety program reduces adverse drug events in a community hospital.
    Cohen MM; Kimmel NL; Benage MK; Cox MJ; Sanders N; Spence D; Chen J
    Qual Saf Health Care; 2005 Jun; 14(3):169-74. PubMed ID: 15933311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experience with a trigger tool for identifying adverse drug events among older adults in ambulatory primary care.
    Singh R; McLean-Plunckett EA; Kee R; Wisniewski A; Cadzow R; Okazaki S; Fox C; Singh G
    Qual Saf Health Care; 2009 Jun; 18(3):199-204. PubMed ID: 19468002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance of International Classification Of Diseases, 9th Revision, Clinical Modification codes as an adverse drug event surveillance system.
    Hougland P; Xu W; Pickard S; Masheter C; Williams SD
    Med Care; 2006 Jul; 44(7):629-36. PubMed ID: 16799357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preventing adverse drug events in hospital practice: an overview.
    Rommers MK; Teepe-Twiss IM; Guchelaar HJ
    Pharmacoepidemiol Drug Saf; 2007 Oct; 16(10):1129-35. PubMed ID: 17610221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Developing indicators of inpatient adverse drug events through nonlinear analysis using administrative data.
    Nebeker JR; Yarnold PR; Soltysik RC; Sauer BC; Sims SA; Samore MH; Rupper RW; Swanson KM; Savitz LA; Shinogle J; Xu W
    Med Care; 2007 Oct; 45(10 Supl 2):S81-8. PubMed ID: 17909388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The EU-ADR project: preliminary results and perspective.
    Trifiro G; Fourrier-Reglat A; Sturkenboom MC; Díaz Acedo C; Van Der Lei J;
    Stud Health Technol Inform; 2009; 148():43-9. PubMed ID: 19745234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.